• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
JIANG Bo,WANG Bailu.The quality management of clinical trials of antiviral drugs against SARS-CoV-2[J].Journal Of Pharmaceutical Research,2023,42(7):471-474[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2232times   Download 2322次 QR Code for this article
Scan with your phone!
抗新型冠状病毒药物临床试验质量管理
姜波1,2,王白璐1,2
Font:Larger+|Default|Smaller-
(1.山东大学齐鲁医院临床试验机构办公室,山东 济南 250012;2.国家药品监督管理局创新药物临床研究与评价重点实验室,山东 济南 250012)
摘要:
结合日常临床试验管理工作实践,本文探讨了抗新型冠状病毒药物临床试验质量管理,阐述质量保证的体系构成和质量控制的实施要点,总结目前抗新型冠状病毒药物临床试验质量面临的问题并提出建议。
关键词:  抗新型冠状病毒药物临床试验  质量管理  质量保证  质量控制
DOI:10.13506/j.cnki.jpr.2023.07.007
基金项目:国家重点研发计划项目(No.2022YFC0868600)
Publication Date:July 25, 2023
The quality management of clinical trials of antiviral drugs against SARS-CoV-2
JIANG Bo1,2,WANG Bailu1,2
(1.Qilu Hospital of Shandong University Clinical Trial Center, Jinan 250000, China; 2.NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drugs,Jinan 250000, China)
Abstract:
Combined with the practice of clinical trial management, this article analyzed the quality management of clinical trials of antiviral drugs against SARS-CoV-2, described the organizational structure of quality assurance and the key points of quality control, summarized the quality problems of clinical trials of antiviral drugs against SARS-CoV-2, and proposed the improvement measures.
Key words:  Clinical trials of antiviral drugs against SARS-CoV-2  Quality management  Quality assurance  Quality control
Today's Visits:483    Total Visits:2383194
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.